Cell Therapy Attenuates Cardiac Dysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold
Juliana S. Nakamuta, Maria E. Danoviz, Fabio L. N. Marques et al. · 2009
Read Cell Therapy Attenuates Cardiac Dysfunction Post Myocardial Infarction: Effect of Timing, Routes of Injection and a Fibrin Scaffold by Juliana S. Nakamuta, Maria E. Danoviz, Fabio L. N. Marques et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0006005.txt.
Description
Cell therapy after a heart attack sounds simple, but the details decide whether it helps. Juliana Nakamuta, Maria Danoviz, Fabio Marques and colleagues varied those details in 2009. Their PLOS ONE study gives bone marrow cells to hearts after infarction. It tests three things: when the cells go in, which route they take, and whether a fibrin scaffold helps them stay.
Each choice softened the heart's decline in its own measure, the team reports. Delivery is thus part of the treatment, not a footnote to it. The work helps trial designers pick timing and route with evidence in hand, a needed step before cell therapy for heart repair can prove itself in patients.
Catalog record
| CREATOR | Juliana S. Nakamuta, Maria E. Danoviz, Fabio L. N. Marques et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0006005